Sharad Sharma

4PUBLICATIONS
36CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 12, 2022
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression.

Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein

|Aug 22, 2020
An orally available non-nucleotide STING agonist with antitumor activity.

Bo-Sheng Pan, Samanthi A Perera, Jennifer A Piesvaux

|Feb 24, 2017
The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1.

Maciej M Markiewski, Surya Kumari Vadrevu, Sharad K Sharma

Pageof 1